Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy - PubMed (original) (raw)

Review

. 1993 May-Aug;4(3-4):172-7.

doi: 10.1159/000107319.

Affiliations

• PMID: 8401788
• DOI: 10.1159/000107319

Review

Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy

P T Francis et al. Dementia. 1993 May-Aug.

Abstract

Non-Alzheimer's dementia due to lobar atrophy had choline acetyltransferase activities comparable with control rather than Alzheimer's disease values, based on 3 autopsy proven cases on Pick's disease and biopsies from 3 examples of dementia of frontal lobe type. Muscarinic cholinergic receptors were relatively spared only in Alzheimer's disease. Serotonin receptors were markedly reduced (based on Pick cases) whereas measures that reflected presynaptic serotonergic activity were either not affected or increased. Cerebrospinal fluid and brain tissue measurements suggested that inhibitory interneurones and dopamine release were relatively spared. There was no in vitro evidence of hypometabolism.

PubMed Disclaimer

Similar articles

• Neurochemical features of frontotemporal dementia.
  Procter AW, Qurne M, Francis PT. Procter AW, et al. Dement Geriatr Cogn Disord. 1999;10 Suppl 1:80-4. doi: 10.1159/000051219. Dement Geriatr Cogn Disord. 1999. PMID: 10436347
• Non-Alzheimer fronto-temporal degenerative dementia. A neurobehavioral and pathologic study.
  Filley CM, Kleinschmidt-De Masters BK, Gross KF. Filley CM, et al. Clin Neuropathol. 1994 May-Jun;13(3):109-16. Clin Neuropathol. 1994. PMID: 8088029
• Lobar atrophy without Pick bodies.
  Hulette CM, Crain BJ. Hulette CM, et al. Clin Neuropathol. 1992 May-Jun;11(3):151-6. Clin Neuropathol. 1992. PMID: 1611728
• [Where fronto-temporal dementia should be placed in the history of Pick's disease and related disorders].
  Ikeda K. Ikeda K. Seishin Shinkeigaku Zasshi. 2000;102(6):529-42. Seishin Shinkeigaku Zasshi. 2000. PMID: 10979314 Review. Japanese.
• Frontal lobe degeneration of non-Alzheimer type.
  Gustafson L, Brun A, Passant U. Gustafson L, et al. Baillieres Clin Neurol. 1992 Nov;1(3):559-82. Baillieres Clin Neurol. 1992. PMID: 1344203 Review.

Cited by

• Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years.
  Carlos AF, Josephs KA. Carlos AF, et al. J Neurol. 2022 Aug;269(8):4030-4054. doi: 10.1007/s00415-022-11073-3. Epub 2022 Mar 23. J Neurol. 2022. PMID: 35320398 Free PMC article. Review.
• GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition.
  Murley AG, Rouse MA, Jones PS, Ye R, Hezemans FH, O'Callaghan C, Frangou P, Kourtzi Z, Rua C, Carpenter TA, Rodgers CT, Rowe JB. Murley AG, et al. Brain. 2020 Dec 5;143(11):3449-3462. doi: 10.1093/brain/awaa305. Brain. 2020. PMID: 33141154 Free PMC article.
• A Clinical Guide to Frontotemporal Dementias.
  Ljubenkov PA, Miller BL. Ljubenkov PA, et al. Focus (Am Psychiatr Publ). 2016 Oct;14(4):448-464. doi: 10.1176/appi.focus.20160018. Epub 2016 Oct 7. Focus (Am Psychiatr Publ). 2016. PMID: 31975825 Free PMC article.
• Neurotransmitter deficits from frontotemporal lobar degeneration.
  Murley AG, Rowe JB. Murley AG, et al. Brain. 2018 May 1;141(5):1263-1285. doi: 10.1093/brain/awx327. Brain. 2018. PMID: 29373632 Free PMC article. Review.
• Evaluation and management of the elderly patient presenting with cognitive complaints.
  Hildreth KL, Church S. Hildreth KL, et al. Med Clin North Am. 2015 Mar;99(2):311-35. doi: 10.1016/j.mcna.2014.11.006. Epub 2014 Dec 23. Med Clin North Am. 2015. PMID: 25700586 Free PMC article. Review.

Publication types

MeSH terms

LinkOut - more resources

• Medical

  • MedlinePlus Health Information